<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> are at high risk of progression to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>A growing, but conflicting body of evidence implicates <z:e sem="disease" ids="C0005403" disease_type="Disease or Syndrome" abbrv="">bile reflux</z:e> as a contributor to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>To investigate whether <z:e sem="disease" ids="C0013299" disease_type="Disease or Syndrome" abbrv="">duodenogastric reflux</z:e> was associated with an increased risk of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, a case-control study of incident <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was performed </plain></SENT>
<SENT sid="3" pm="."><plain>Cases (n=72) were identified by new histologically-confirmed diagnosis of specialized <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (indicative of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>) following upper endoscopy for refractory <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> between October 1997 and September 2000 </plain></SENT>
<SENT sid="4" pm="."><plain>Cases were compared to <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> patients without specialized <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (controls; n=72) </plain></SENT>
<SENT sid="5" pm="."><plain>There was no difference in total <z:chebi fb="0" ids="3098">bile acid</z:chebi> concentrations between cases and controls </plain></SENT>
<SENT sid="6" pm="."><plain>Risk of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> did not significantly vary with increasing concentrations of total or free <z:chebi fb="1" ids="3098">bile acids</z:chebi>, respectively (OR 0.35 (95% CI 0.12, 1.02) and 0.60 (95% CI 0.22, 1.66)) </plain></SENT>
<SENT sid="7" pm="."><plain>Low gastric fluid pH (toxic range 3-5), was associated with a non-significant increase in the risk of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In conclusion, no significant association between <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and total or free <z:chebi fb="1" ids="3098">bile acids</z:chebi> in gastric refluxate was found </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with low gastric fluid pH (3-5) may represent a subset of patients at high risk of developing <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
</text></document>